Moreover, PRL-1 and RhoA mRNA levels in CP-MSCs and WI-38 cells treated with LCA were significantly higher compared with no treatment (# p < 0.05, Figure 5D,E). The gene discussed is PTP4A1; the disease is Leber congenital amaurosis.